Thank you, Operator, and welcome, everyone, to the Nanalysis Scientific’s fourth quarter and full year 2024 conference call.

European pharma giant Roche beat first-quarter sales expectations on Thursday, while drug brethren Sanofi came in with a mixed sales report. But shares of both remained muted.Roche's total sales grew ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump’s ...